Skip to main content
. 2013 Sep 30;85(4):154–160. doi: 10.4174/jkss.2013.85.4.154

Fig. 1.

Fig. 1

Study design. SD, stable disease; PD, progressive disease; FOLFIRI, 5-flurouracil/leucovorin with irinotecan; CTx, chemotherapy.